ARCHIVES

Final Results from CLEOPATRA Phase III Trial Show Perjeta Increased OS 15.7 Months

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

President’s Cancer Panel Lists Recommendations For Improving Quality Of Cancer Care

April 9, 1999

Cancer Program Advocates, Success Overcame Powerful Negative Factors To Win Budget Fight

August 10, 1979

Drug Combination Tested For B.C. Brain Metastases

January 25, 2008

Bevacizumab And Irinotecan May Increase Survival Of GBM

October 26, 2007

Galeterone Shows Potential In CRPC AR Variants, Study Says

November 28, 2014

New Coalition To Lobby for Prevention

November 24, 1978